PTLD
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) (NCT04138875) | Yale University | 2022-01-01 |
| Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV (NCT05258136) | Beijing Friendship Hospital | 2021-06-01 |
| Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD) (NCT03086395) | Case Comprehensive Cancer Center | 2017-04-01 |
| CNTRP POSITIVE Study (NCT02318030) | The Hospital for Sick Children | 2014-04-01 |
| Risk Stratified Sequential Treatment for CD20-positive PTLD (NCT00590447) | Charite University, Berlin, Germany | 2006-12-01 |
Track PTLD automatically
Every clearance here is in the API, with alerts when new ones post.